Ominimo Hits Unicorn Status Following $1.6 Billion Series B Funding

Insurtech Ominimo closed a Series B at a $1.6 billion valuation, according to The SaaS News. The company is two years old. The round amount is undisclosed. The lead investor is a multilateral development bank, not a venture firm. The headline figure deserves a hard look.

Deal Mechanics

The Series B closed July 27, 2026. The European Bank for Reconstruction and Development (EBRD) led. Ominimo did not disclose the cash raised, the round structure, or participating co-investors beyond the lead. The $1.6 billion number reflects post-money valuation — not capital deployed.

EBRD's role is the structural tell. EBRD is a multilateral development institution, not a growth-equity fund. When a development bank leads a Series B, the underwriting logic is regional economic strategy, not venture-IRR optimization. The capital is real. The signaling is institutional, not financial.

The Operating Profile

Ominimo was founded in 2024 by Dusan Komar, Dennis Weinbender, and Laslo Horvath. The company is Serbian-Hungarian. The product is motor insurance distributed via proprietary AI and segmented data-driven pricing models. Current markets: Hungary, Poland, Netherlands, Sweden. Stated expansion targets: Belgium, Romania, Spain, Italy, France, and the United States by 2027.

Two years from founding to $1.6B. Four markets live. Motor insurance — a regulated category with established local incumbents in every market listed. The wedge is algorithmic pricing precision versus legacy actuarial stacks. Speed of expansion depends on what each market will accept.

What to Track

Three data points will determine whether $1.6B is a milestone or a marker:

• Loss ratio. Combined ratio by market. Motor insurance economics live or die on this figure. Not disclosed.
• GWP. Gross written premium is the insurance equivalent of ARR. Undisclosed. The valuation multiple is impossible to compute without it.
• Geographic contribution. Four markets live; revenue split by country not public. Concentration risk is unknown.

For founders in European insurtech: this round resets the pricing benchmark on the continent. Any Series A in motor or property insurtech across Europe will now be measured against Ominimo's implied multiple — which, for now, is a number without a denominator.